1. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1297,
2001,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
2. |
Reviewing the management of endometriosis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1297,
2001,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
3. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1297,
2001,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
4. |
Basiliximab less costly than ATG in renal transplantation |
|
Inpharma Weekly,
Volume &NA;,
Issue 1297,
2001,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
5. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1297,
2001,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
6. |
Update on biotech drugs for psoriasis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1297,
2001,
Page 7-8
Carmen Innes,
Preview
|
|
摘要:
Earlier on in the year, encouraging data for several new biotech agents for psoriasis were reported at the American Academy of Dermatology (AAD) meeting.*Updated clinical results have now been presented for two of the most promising of these drugs, efalizumab ['Xanelim'] and alefacept ['Amevive'], at the 2nd Joint Meeting of the International Psoriasis Symposium and the European Congress on Psoriasis [San Francisco, US; June 2001], showing that both are very effective in patients with moderate-to-severe psoriasis. The two agents are in hot competition with each other to reach the psoriasis market, with registration proceedings expected within the next year. In addition, phase II data show that the antisense drug ISIS 2302 reduces the thickness of psoriatic plaques and phase I/II data reveal that the monoclonal antibody MEDI-507 is effective and well tolerated in patients with psoriasis.
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
7. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1297,
2001,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
8. |
Alitretinoin + tamoxifen active in metastatic breast cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1297,
2001,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
9. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1297,
2001,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
10. |
Esomeprazole effectively eases heartburn in patients with GORD |
|
Inpharma Weekly,
Volume &NA;,
Issue 1297,
2001,
Page 11-12
Sushma Soni,
Preview
|
|
摘要:
A number of studies have shown esomeprazole, an isomer of omeprazole, to produce greater and more sustained gastric acid suppression than omeprazole, due to its greater systemic bioavailability. Several posters presented at Digestive Disease Week [Atlanta, US; May 2001] examined the effect of esomeprazole on gastro-oesophageal reflux disease (GORD) symptoms such as heartburn, particularly in patients with a history of erosive oesophagitis. Esomeprazole was shown to effectively control these symptoms and to provide superior gastric acid control, compared with standard dosages of other proton pump inhibitors (PPIs).
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|